Biogen Inc. buy Truist Financial Co.
Start price
16.05.24
/
50%
€210.90
Target price
16.05.25
€312.83
Performance (%)
-10.64%
Price
02.08.24
€188.45
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -10.64%. This prediction currently runs until 16.05.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.086% | -3.086% |
iShares Core DAX® | -3.935% | -2.628% |
iShares Nasdaq 100 | -3.608% | -9.283% |
iShares Nikkei 225® | -4.513% | -6.951% |
iShares S&P 500 | -2.607% | -4.402% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat